AGP Executive Report
Last update: 11 hours agoPharma Access: Australia’s PBS expands discounted Keytruda (pembrolizumab) listings for new advanced cancers, expected to help about 700 patients a year and cut out-of-pocket costs dramatically. Cardiovascular Evidence: The STAREE trial finds atorvastatin lowers major cardiovascular events by 30% in healthy adults aged 70+ but doesn’t improve disability-free survival—useful for older-age prescribing debates. Cyber & Fraud: Australians are being warned after recent breaches hit major firms, with attackers able to stitch together personal details across incidents—raising the stakes for identity security. Financial Crime Cooperation: Five Eyes partners, including Australia, back UK-led steps to disrupt global fraud networks via faster intelligence-sharing and coordinated account takedowns. Market & Investing Angle: Gold slips after US Fed remarks in Jackson Hole, though prices remain above earlier-month levels; investors are watching rate expectations closely. Regulatory/Markets Watch: Hong Kong’s SFC flags SBCFX and related entities as unlicensed after a trading collapse that left investors exposed to USDT losses. Housing Pressure (Local): Brisbane families seeking an extra bedroom are being priced out by hundreds of thousands, highlighting how housing scarcity is reshaping household budgets.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
